Xcout Intel
FEMSelect
FEMSelect is a medical equipment manufacturing company that developed the EnPlace system for minimally invasive pelvic organ prolapse treatment. The company has historically maintained operations originating from Israel while shifting its strategic headquarters toward the United States.
Subscribe to see FEMSelect’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FEMSelect at a glance
FEMSelect is a surgical devices company headquartered in Israel. Its most recent funding round, Series B, raised $9M in October 2022. Xcout tracks 14 named people at FEMSelect, including Sasha Schrode (Chief Executive Officer, Femselect).
FEMSelect leadership
- Sasha SchrodeChief Executive Officer, Femselect
- Debbie GarnerPresident, Femselect
- Dani GoldsherCFO, Triventures
- Boaz HarariFounder VP Research & Development
- Dr. Peter FitzgeraldCo-Founder Managing Partner, Triventures ▸ Director, Center for Cardiovascular Technology, Stanford University
- Menahem NeumanFounder & Medical Director
8 more named people on record for FEMSelect, with roles, board committees and tenure — see the full roster →
FEMSelect funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $9M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
FEMSelect competitors
A few of FEMSelect's closest competitors — see the full list of competitors and alternatives →
OCON Therapeutics is a medical device company founded in 2011 and headquartered in Modiin, Israel, dedicated to creating new standards of care for women's health.
Inlet Medical Inc. is a medical device company that develops products targeting the women's surgery market, including a laparoscopic suturing tool.
Herniamesh is an Italian company that manufactures and internationally distributes surgical medical devices for inguinal and abdominal hernia repair, as well as for the treatment of female urinary incontinence and pelvic floor prolapse. The company serves medical professionals and surgeons by providing research-backed, quality-assured medical products.
Medical Surgery Technologies (MST) is an Israeli medical-device company that develops robotic and computer-assisted technologies for minimally invasive laparoscopic surgery. Its products include automated laparoscope positioning and visualization systems intended to assist surgeons and operating-room teams in hospitals.
UroMems is a global medical device and biotechnology company headquartered in Eybens, France, developing innovative mechatronic implants like the UroActive system to treat urinary incontinence.
Strauss Surgical USA LLC develops and supplies minimally invasive medical devices and solutions specializing in endourology, focusing on bipolar resection products for prostate and bladder care, along with high-flow resection sheaths and HD cystoscopes. The company also offers products for arthroscopy and hysteroscopy, serving urologists and medical facilities.
Get FEMSelect's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on FEMSelect in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access